Skip to main content

Table 5 Acute toxicity assessment (based on RTOG acute skin scoring)

From: A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects

 

G0

G1

G2

G3

N0 of patients

Treatment end

34 (52%)

25 (39%)

6 (9%)

0

65

3 months

40 (62%)

19 (29%)

6 (9%)

0

65

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us